(+)-dexrazoxane increases expression ISO RGD:734072 6480464 Dexrazoxane results in increased expression of ATP5O mRNA CTD PMID:26873546 1,2-dimethylhydrazine multiple interactions ISO RGD:734072 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5O mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:734072 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5O mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:734072 6480464 Ethinyl Estradiol results in increased expression of ATP5O mRNA CTD PMID:17555576 , PMID:17942748 17beta-estradiol affects binding EXP 6480464 ATP5PO protein binds to Estradiol CTD PMID:10096774 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5PO protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:734072 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5O mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5PO mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ATP5PO mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5PO mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:734072 6480464 Tetrachlorodibenzodioxin affects the expression of ATP5O mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734072 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5O mRNA CTD PMID:17942748 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of ATP5PO mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:734072 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ATP5O mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1348097 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ATP5PO protein CTD PMID:34186270 5-fluorouracil multiple interactions ISO RGD:1348097 6480464 ATP5PO mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] CTD PMID:17327601 5-formyltetrahydrofolic acid multiple interactions ISO RGD:1348097 6480464 ATP5PO mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] CTD PMID:17327601 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP5PO mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1348097 6480464 Antirheumatic Agents results in increased expression of ATP5PO mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:1348097 6480464 arsenite promotes the reaction [G3BP1 protein binds to ATP5PO mRNA] CTD PMID:32406909 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ATP5PO mRNA CTD PMID:27114639 atrazine decreases expression ISO RGD:1348097 6480464 Atrazine results in decreased expression of ATP5PO mRNA CTD PMID:22378314 , PMID:27114639 benzo[a]pyrene increases methylation ISO RGD:1348097 6480464 Benzo(a)pyrene results in increased methylation of ATP5O promoter CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:1348097 6480464 benzo(e)pyrene results in decreased methylation of ATP5O intron CTD PMID:30157460 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP5PO mRNA CTD PMID:17010207 , PMID:25181051 bisphenol A decreases expression ISO RGD:1348097 6480464 bisphenol A results in decreased expression of ATP5PO protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1348097 6480464 bisphenol A results in decreased methylation of ATP5PO gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:734072 6480464 bisphenol A results in increased expression of ATP5O mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:1348097 6480464 bisphenol A affects the expression of ATP5O mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP5PO mRNA CTD PMID:30816183 , PMID:32528016 Bisphenol B increases expression ISO RGD:1348097 6480464 bisphenol B results in increased expression of ATP5PO protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1348097 6480464 bisphenol F results in increased expression of ATP5PO protein CTD PMID:34186270 bleomycin A2 decreases expression ISO RGD:734072 6480464 Bleomycin results in decreased expression of ATP5O protein CTD PMID:29733421 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of ATP5PO protein CTD PMID:28903499 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATP5PO mRNA CTD PMID:33453195 cannabidiol multiple interactions ISO RGD:1348097 6480464 [Cuprizone co-treated with Cannabidiol] results in increased expression of ATP5O protein CTD PMID:34122009 carbon nanotube increases expression ISO RGD:734072 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube affects expression ISO RGD:734072 6480464 Nanotubes, Carbon affects the expression of ATP5O protein CTD PMID:21135415 CGP 52608 multiple interactions ISO RGD:1348097 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATP5O gene] CTD PMID:28238834 chloropicrin affects expression ISO RGD:1348097 6480464 chloropicrin affects the expression of ATP5PO mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:1348097 6480464 chloropicrin results in decreased expression of ATP5PO mRNA CTD PMID:28476498 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ATP5PO protein CTD PMID:22023808 clobetasol increases expression ISO RGD:734072 6480464 Clobetasol results in increased expression of ATP5O mRNA CTD PMID:27462272 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of ATP5PO protein CTD PMID:20118634 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP5PO mRNA CTD PMID:17602206 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ATP5PO mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ATP5PO mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:1348097 6480464 Copper Sulfate results in decreased expression of ATP5PO mRNA CTD PMID:19549813 Cuprizon multiple interactions ISO RGD:1348097 6480464 [Cuprizone co-treated with Cannabidiol] results in increased expression of ATP5O protein CTD PMID:34122009 cyclosporin A decreases expression ISO RGD:1348097 6480464 Cyclosporine results in decreased expression of ATP5PO mRNA CTD PMID:25562108 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ATP5PO mRNA CTD PMID:21266533 dihydroartemisinin affects binding ISO RGD:1348097 6480464 artenimol analog binds to ATP5PO protein CTD PMID:26340163 doxorubicin affects expression ISO RGD:1348097 6480464 Doxorubicin affects the expression of ATP5O protein CTD PMID:29385562 doxorubicin increases expression ISO RGD:1348097 6480464 Doxorubicin results in increased expression of ATP5PO mRNA CTD PMID:29803840 etoposide decreases expression ISO RGD:734072 6480464 Etoposide results in decreased expression of ATP5O protein CTD PMID:29733421 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of ATP5PO mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATP5PO mRNA CTD PMID:24136188 flutamide decreases expression ISO RGD:734072 6480464 Flutamide results in decreased expression of ATP5O mRNA CTD PMID:19442681 folic acid multiple interactions ISO RGD:734072 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5O mRNA CTD PMID:22206623 genistein increases expression EXP 6480464 Genistein results in increased expression of ATP5PO mRNA CTD PMID:17010207 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ATP5PO mRNA CTD PMID:33387578 irinotecan multiple interactions ISO RGD:1348097 6480464 ATP5PO mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with Irinotecan] CTD PMID:17327601 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5PO mRNA CTD PMID:30303030 ivermectin decreases expression ISO RGD:1348097 6480464 Ivermectin results in decreased expression of ATP5PO protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:1348097 6480464 ATP5O protein affects the susceptibility to Josamycin CTD PMID:31915244 lamivudine multiple interactions ISO RGD:734072 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5O mRNA CTD PMID:18313992 lead(0) affects expression ISO RGD:1348097 6480464 Lead affects the expression of ATP5PO mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1348097 6480464 Lead affects the expression of ATP5PO mRNA CTD PMID:28903495 menadione affects expression ISO RGD:1348097 6480464 Vitamin K 3 affects the expression of ATP5PO mRNA CTD PMID:20044591 methapyrilene decreases methylation ISO RGD:1348097 6480464 Methapyrilene results in decreased methylation of ATP5O intron CTD PMID:30157460 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP5PO mRNA CTD PMID:17602206 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of ATP5PO mRNA CTD PMID:20360939 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of ATP5PO mRNA CTD PMID:17010207 paracetamol affects expression ISO RGD:734072 6480464 Acetaminophen affects the expression of ATP5O mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1348097 6480464 Acetaminophen results in decreased expression of ATP5O mRNA CTD PMID:29067470 , PMID:31059760 paracetamol increases expression ISO RGD:734072 6480464 Acetaminophen results in increased expression of ATP5O protein CTD PMID:21329376 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of ATP5PO mRNA CTD PMID:21251948 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:734072 6480464 perfluorooctane sulfonic acid results in decreased expression of ATP5O mRNA CTD PMID:20936131 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ATP5PO mRNA CTD PMID:19162173 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of ATP5PO mRNA CTD PMID:15170462 resveratrol increases expression ISO RGD:734072 6480464 resveratrol results in increased expression of ATP5O mRNA CTD PMID:22610192 rotenone increases expression ISO RGD:1348097 6480464 Rotenone results in increased expression of ATP5PO mRNA CTD PMID:18191903 rotenone decreases expression ISO RGD:734072 6480464 Rotenone results in decreased expression of ATP5O mRNA CTD PMID:23186747 sarin decreases expression ISO RGD:1348097 6480464 Sarin results in decreased expression of ATP5PO mRNA CTD PMID:19522546 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ATP5PO protein CTD PMID:29459688 Soman decreases expression EXP 6480464 Soman results in decreased expression of ATP5PO mRNA CTD PMID:19281266 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ATP5PO protein CTD PMID:19634143 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5PO protein] CTD PMID:19634143 tamoxifen affects expression ISO RGD:734072 6480464 Tamoxifen affects the expression of ATP5O mRNA CTD PMID:17555576 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ATP5PO mRNA CTD PMID:34492290 tolcapone affects binding EXP 6480464 tolcapone binds to ATP5PO protein CTD PMID:19783845 tungsten increases expression ISO RGD:734072 6480464 Tungsten results in increased expression of ATP5O mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1348097 6480464 Valproic Acid affects the expression of ATP5PO mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1348097 6480464 Valproic Acid results in increased methylation of ATP5O gene CTD PMID:29501571 vanadium atom increases expression ISO RGD:1348097 6480464 Vanadium results in increased expression of ATP5PO mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:1348097 6480464 Vanadium results in increased expression of ATP5PO mRNA CTD PMID:19000753 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ATP5PO mRNA CTD PMID:23555832 zidovudine multiple interactions ISO RGD:734072 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5O mRNA CTD PMID:18313992 zidovudine increases expression ISO RGD:1348097 6480464 Zidovudine results in increased expression of ATP5PO mRNA CTD PMID:16894629 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of ATP5PO mRNA CTD PMID:12672911 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of ATP5PO mRNA CTD PMID:12672911